Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€34.89
29.07.22
-
29.07.23
-26.25%
29.07.23

buy
US Physical Therapy Inc.

Start price
Target price
Perf. (%)
€122.00
26.07.22
-
26.07.23
-9.84%
26.07.23

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

Fluidigm Corp.

Start price
Target price
Perf. (%)
€1.68
27.06.22
-
27.06.23
-10.79%
24.04.23

Probably not worthwhile Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.24
24.06.22
€5.00
24.06.23
-1.57%
26.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
buy
Bovie Medical Corp

Start price
Target price
Perf. (%)
€5.90
28.05.22
-
28.05.23
-55.93%
24.04.23

Risky Investment
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.42
16.05.22
-
16.05.25
-53.44%
11.03.24

Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.42
15.05.22
-
15.05.23
81.90%
24.04.23

Risky Investment
Growths slower than the competition
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€36.83
03.05.22
€30.00
03.05.23
-38.60%
11.03.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.77
28.04.22
€25.00
28.04.23
19.70%
03.05.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€7.59
01.04.22
€12.50
01.04.23
-76.56%
04.03.23

Could be worthwhile Investment >10% per year
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€8.50
30.03.22
-
30.03.23
-24.12%
31.03.22

Risky Investment
buy
Evolent Health Inc

Start price
Target price
Perf. (%)
€28.40
29.03.22
-
29.03.23
-0.70%
29.03.23

Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€54.20
16.03.22
€65.00
16.03.23
-43.24%
28.04.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc

Start price
Target price
Perf. (%)
€46.58
14.03.22
€35.00
14.03.23
16.36%
16.03.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€64.00
30.01.22
€65.00
30.01.23
-27.22%
14.03.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€246.90
30.01.22
€270.00
30.01.23
-9.98%
31.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year